Silicon Canals
No Result
View All Result
  • Home
  • News
    • News
    • Startups
    • Scaleups
    • AI and chatbots
    • FinTech
    • Business Wire
    • Travel & Mobility
    • Coin Canals
    • Software & SaaS
    • Event News
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Exclusive content
    • Partner content
    • Amsterdam
    • Community partners
    • Remote: Tech Talent Report
    • Guest Contributions
  • Find a job
  • Tech Events
    • Technology Events
    • Event News
    • Submit event
  • Contact
    • Contact us
    • Sign up for our newsletter!
    • Contribute your content
    • Team
    • About us
  • Partner with us
  • Home
  • News
    • News
    • Startups
    • Scaleups
    • AI and chatbots
    • FinTech
    • Business Wire
    • Travel & Mobility
    • Coin Canals
    • Software & SaaS
    • Event News
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Exclusive content
    • Partner content
    • Amsterdam
    • Community partners
    • Remote: Tech Talent Report
    • Guest Contributions
  • Find a job
  • Tech Events
    • Technology Events
    • Event News
    • Submit event
  • Contact
    • Contact us
    • Sign up for our newsletter!
    • Contribute your content
    • Team
    • About us
  • Partner with us
No Result
View All Result
Silicon Canals
No Result
View All Result
This article is produced in collaboration with our partner StartupAmsterdam

Amsterdam-based Clear.bio raises funds from Achmea to help people deal with Type 2 diabetes

Vishal Singh by Vishal Singh
November 18, 2022
in (Crowd)funding, Amsterdam, Partner content
Clear.bio

Image credit: Clear.bio

LinkedInTwitterWhatsAppFacebook
Read this article in:

Amsterdam-based Clear.bio is a startup that measures blood glucose levels in real-time using a chip-implanted arm patch and an app. The company announced on Wednesday, November 9, that it has raised fresh funding from Amsterdam’s Achmea Innovation Fund. The investment amount remains undisclosed.

Achmea Innovation Fund invests in startups that have strategic alignment with Achmea – the largest insurer in the Netherlands. Katharina Maass, manager of Achmea Innovation Fund, says, “This is in keeping with our ambition to invest in affordable digital business models that help solve social issues, in this case relating to health. And of course, it also links with Zilveren Kruis’ mission to bring healthcare a step closer to all of us.”

Besides the Achmea Fund, Clear.bio’s co-founder, Piet Hein van Dam reports that existing investors such as Future Food Fund and Antler, have also invested in this round.

Prior to this, in March 2022, the Amsterdam healthtech startup raised €1M from food & agriculture VC Future Food Fund, Rabobank, and several prominent angels.

Helping people with a healthier lifestyle through data

Founded in 2019 by Madelon Bracke and Piet Hein van Dam, Clear.bio has developed a digital self-help tool that helps users to put together a fully personalised diet and to follow it in their day-to-day lives. The healthtech startup helps people with type 2 diabetes to be “the best and healthiest version of themselves using data instead of pills”.

Data-driven and personalised dietary advice, supported with personal guidance and step-by-step adjustments, ensure effective and sustainable changes in the diet. Clear.bio takes these success factors as the starting point for a mobile application. In the app, you log everything you eat, drink and your activity. The Clear.bio algorithm then determines the nutritional score of your meals and helps you build your own optimal nutrition plan.

Co-founder Piet Hein van Dam, says, “Real-time biodata, a smart app and nutrition coaches (via the app) provide our users with 100 per cent personal nutritional advice and 24/7 assistance to improve their eating habits and health at home themselves. We bring healthcare to the patient instead of the other way around. Digital healthcare solutions are the future: they are personalised, real-time, continuously available and give a much greater sense of control, wherever you are, even when you’re on holiday.”

Increase quality of life

The Diabetesvereniging Nederland (the Dutch Diabetes Association) and Zilveren Kruis collaborated with social partner Clear.bio to perform two pilots with patients with type 2 diabetes during the previous six months. When compared to health, patient motivation, and healthcare delivery, the outcomes of these initial pilot programmes are encouraging. In three months, several individuals were able to stop or improve their condition.

According to a statement from Clear.bio, in the Netherlands, type 2 diabetes affects over a million people, making it a major social issue. Additionally, this number is increased by thousands of new patients each week. Obviously, this has a significant effect on the individuals themselves and results in growing healthcare expenses. Clear.bio helps them learn how to enhance their quality of life and become more independent. It also lessens the strain on medical professionals.

Tags: amsterdamfeaturedfundingnews
ShareTweetSendShare

Partner content | Partner with us

Bunq’s Ali Niknam receives ‘Businessman of the Year’ award: Know more

Belgium’s Fortino Capital closes second PE fund at €377M; backs Amsterdam-based SpeakUp

Amsterdam-based Return unveils second €100M investment to drive energy transition in Europe

Amsterdam’s Rockstart launches its second AgriFood fund; plans to invest in 50 startups in five years

Amsterdam’s Farmless raises €4.8M to free protein production from animals and agricultural land

Silicon Canals | Find a job

Top news | from Amsterdam

Check out the Amsterdam startups that raised funding in November; 5 of them are hiring

Amsterdam-based startups that are fundraising right now

Dutch-Swiss startup Cradle raises €21.9M for pioneering Generative AI in protein design

Germany’s Sastrify expands market reach; acquires Amsterdam-based Pengu and raises fresh funds

Amsterdam’s LAYCO raises €300K to make healthcare more sustainable and accessible

  • About Silicon Canals
  • Partner with Silicon Canals
  • Impressum
  • Contact us
  • Sign up for our newsletter!
  • Find a job
  • Disclaimer
  • Privacy Policy
  • Cookie Policy (UK)
  • Cookie Policy (EU)
  • Terms & Conditions Silicon Canals

Silicon Canals © 2014-2023 | Design: Bright Idiots. Images: Depositphotos

No Result
View All Result
  • Home
  • News
    • News
    • Startups
    • Scaleups
    • AI and chatbots
    • FinTech
    • Business Wire
    • Travel & Mobility
    • Coin Canals
    • Software & SaaS
    • Event News
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Exclusive content
    • Partner content
    • Amsterdam
    • Community partners
    • Remote: Tech Talent Report
    • Guest Contributions
  • Find a job
  • Tech Events
    • Technology Events
    • Event News
    • Submit event
  • Contact
    • Contact us
    • Sign up for our newsletter!
    • Contribute your content
    • Team
    • About us
  • Partner with us

Silicon Canals © 2014-2023 | Design: Bright Idiots. Images: Depositphotos

X
X